Potential use of D-dimer measurement in patients treated with oral anticoagulant for a venous thromboembolic episode

International Angiology

Volumn 22, Issue 4, 2003, Pages 364-369

  Ombandza Moussa, E ^a   Samama, M M ^a   Horellou, M H ^a   Elalamy, I ^a   Conard, J ^a  

^a HÔTEL DIEU   (France)

Author keywords

Anticoagulants; Fibrin fibrinogen degradation products; Thrombophilia; Venous thrombosis, prevention and control

Indexed keywords

ANTICOAGULANT AGENT; D DIMER;

ADOLESCENT; ADULT; AGED; ANALYZER; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEEP VEIN THROMBOSIS; DEVICE; DIAGNOSTIC VALUE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; INTERNATIONAL STANDARD UNIT; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROTEIN BLOOD LEVEL; RECURRENCE RISK; RECURRENT DISEASE; STATISTICAL SIGNIFICANCE; THROMBOPHILIA; VENOUS THROMBOEMBOLISM;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; BLOOD CHEMICAL ANALYSIS; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 1542316114     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Bounameaux H, de Moerloose P, Perrier A, Reber G. Plasma measurement of D-dimer as a diagnostic aid in suspected venous thromboembolism: an overview. Thromb Haemost 1994;71:1-6.
2. de Moerloose P. D-dimer assays for the exclusion of venous thromboembolism which diagnostic strategy? Thromb Haemost 2000;83:180-1.
3. Perrier A, Desmarais S, Miron MJ, de Moerloose P, Lepage R, Slosman D et al. Non-invasive diagnosis of pulmonary venous thromboembolism in outpatients including clinical probability, D-dimer and ultrasonography. Lancet 1999;353:190-5.
4. Lebrun E, Maitre B, Grenier-Sennelier C, Katsahian S, Gouault-Heilmann M, Vasile N et al. Effect of D-dimer testing on the diagnostic strategy of suspected pulmonary embolism: an observational study of practice patterns and costs. Eur Radiol 2000;10 Suppl 3:433-4.
5. Kevorkian JP, Halimi C, Segrestaa JM, Drouet L, Soria C. Monitoring of patients with deep-vein thrombosis during and after anticoagulation with D-dimer. Lancet 1998; 351:571-2.
6. Kevorkian JP, Aparicio C, Mazoyer E, Bonnin P, Duet M, Warnet D et al. A new clinical interest for D-dimer determination: follow-up of patients with deep vein thrombosis [abstract]. Thromb Haemost 2001;86 Supp:P725.
7. Palareti G, Legnani C, Cosmi B, Guazzaloca G, Pancani C, Coccheri S. Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped. Thromb Haemost 2002;87:7-12.
8. de Moerloose P, Bounameaux H, Perrier A, Reber G. Performances of the VIDAS D-dimer new assay for the exclusion thromboembolism. Thromb Haemost 2001;85:185-6.
9. Arcelus JI, Caprini JA, Hoffman KN, Fink N, Size GP, Fareed J et al. Laboratory assays and duplex scanning outcomes after symptomatic deep vein thrombosis: preliminary results. J Vasc Surg 1996;23:616-21.
10. Elias A, Bonfils S, Daoud-Elias M, Gauthier B, Sié P, Boccalon H et al. Influence of long term oral anticoagulants upon prothrombin fragment 1+2, thrombin-antithrombin III complex and D-dimer levels in patients affected by proximal deep vein thrombosis. Thromb Haemost 1993;69:302-5.
11. Sié P, Cadroy Y, Elias A, Boccalon H, Boneu B. D-dimer levels in patients with long-term antecedents of deep venous thrombosis. Thromb Haemost 1994;72:161-2.
12. Cadroy Y, Pierrejean D, Fontan B, Sié P, Boneu B. Influence of aging on the activity of the hemostatic system: prothrombin fragment 1+2, thrombin-antithrombin III complexes and D-dimer in 80 healthy subjects with age ranging from 20 to 94 years. Nouv Rev Fr Hématol 1992; 34:43-6.
13. Tardy B, Tardy-Poncet B, Viallon A, Lafon P, Page Y, Venet C et al. Evaluation of D-dimer ELISA test in elderly patients with suspected pulmonary embolism. Thromb Haemost 1998;79:38-41.
14. Le Blanche AF, Siguret V, Settegrana C, Bohus S, Le Masne de Chermont E, Andreux JP et al. Ruling out acute deep vein thrombosis by ELISA plasma D-dimer assay versus ultrasound in inpatients more than 70 years old. Angiology 1999;50:873-82.
15. Mitusch R, Siemens HJ, Garbe M, Wagner T, Sheikhzadeh A, Diederich KW. Detection of a hypercoagulable state in nonvalvular atrial fibrillation and the effect of anticoagulant therapy. Thromb Haemost 1996;75:219-23.
16. Roldan V, Marin F, Marco P, Climent V, Martinez JG, Monmeneu JV et al. Anticoagulant therapy modifies fibrinolytic dysfunction in chronic atrial fibrillation. Haemostasis 2000;30:219-24.
17. Lowe GD, Haverkate F, Thompson SG, Turner RM, Bertina RM, Turpie AG et al. Prediction of deep vein thrombosis after elective hip replacement surgery by preoperative clinical and haemostatic variables: The ECAT DVT study. Thromb Haemost 1999;81:879-86.
18. De Groot MR, Njo TL, Marwijk Kooy MV, Buller HR. Abrupt versus gradual withdrawal of vitamin K antagonist treatment in patients with venous thromboembolic disease: assessment of hypercoagulability and clinical outcome. Clin Lab 2000;46:575-81.
19. Fattorini A, Crippa L, Vigano D'Angelo S, Pattarini E, D'Angelo A. Risk of deep vein thrombosis recurrence: high negative predictive value of D-dimer performed during oral anticoagulation. Thromb Haemost 2002;88: 162-3.
20. Levine MN, Hirsh J, Gent M, Turpie AG, Weitz J, Ginsberg J et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis. Thromb Haemost 1995;74:606-11.
21. Schulman S, Rhedin AS, Lindmarker P, Carlsson A, Lärfars G, Nicol P et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. N Engl J Med 1995;332:1661-5.
22. Schulman S, Granqvist S, Holmström M, Carlsson A, Lindmarker P, Nicol P et al. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. N Engl J Med 1997;336:393-8.
23. Kearon C, Gent M, Hirsh J, Weitz J, Kovacs MJ, Anderson DR et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med 1999;340:901-7.
24. Agnelli G, Prandoni P, Santamaria MG, Bagatella P, Iorio A, Bazzan M et al. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. N Engl J Med 2001;345:165-9.
25. Pinede L, Ninet J, Duhaut P, Chabaud S, Demolombe-Rague S, Durieu I et al. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation 2001;103: 2453-60.